Publication | Closed Access

Microglia-derived HIV Nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of Nef peptides

EngineeringNef PeptidesImmunologyNanomedicine-based DeliveryBiomedical EngineeringTherapeuticsImmunotherapyNeuroinflammationNanomedicineNeuroimmunologyCell-based Drug DeliveryImmunoengineeringBrain-immune InteractionNeuroprotectionImmune FunctionHivBlood–brain BarrierDrug Delivery SystemsMedicineViral Immunity